New study finds Ozempic and Mounjaro protect the heart too

The study showcasing the cardiovascular benefits of Ozempic and Mounjaro in reducing heart attack and stroke risk among type 2 diabetes patients is crucial for healthcare providers. This evidence highlights the potential of these GLP-1-based drugs to not only manage diabetes but also offer significant cardiovascular protection, impacting treatment strategies and patient outcomes.